Literature DB >> 30345537

Hepatic encephalopathy: Sometimes more portal than hepatic.

Maria-Angeles Aller1, Natalia Arias2,3, Javier Blanco-Rivero4, Jorge L Arias3,5, Jaime Arias1.   

Abstract

Hepatic encephalopathy is a severe complication of both chronic and acute liver diseases. The term hepatic encephalopathy stems from the belief that hepatic insufficiency is its fundamental etiopathogenic factor. However, most clinical cases show liver failure along with mesenteric venous portal hypertension. This portal hypertension would explain the abnormal mechanical forces suffered by the digestive tract in the early stages of the disorder. These forces could regulate some gut biochemical pathological pathways in a process known as mechanotransduction. Thus, portal hypertension would begin with the establishment of a mechanotransduced afferent or sensory inflammatory gut-brain pathway, resulting in functional and structural changes in the central nervous system. In this review, we will revisit the term "hepatic encephalopathy" in light of new results where portal hypertension occurs before liver failure and is accompanied by brain changes. Moreover, we will point out cellular links that can explain the microbiota, immune, gut, and brain axis disturbances found in this disorder.
© 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  glia; gut-brain axis; inflammation; mast cells; portal hypertension; pre-hepatic stenosis

Mesh:

Year:  2018        PMID: 30345537     DOI: 10.1111/jgh.14514

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  2 in total

1.  A multi-omic study for uncovering molecular mechanisms associated with hyperammonemia-induced cerebellar function impairment in rats.

Authors:  Sonia Tarazona; Héctor Carmona; Ana Conesa; Marta Llansola; Vicente Felipo
Journal:  Cell Biol Toxicol       Date:  2021-01-06       Impact factor: 6.691

2.  Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.

Authors:  Lukas Burghart; Emina Halilbasic; Philipp Schwabl; Benedikt Simbrunner; Albert Friedrich Stättermayer; Oleksandr Petrenko; Bernhard Scheiner; David Bauer; Matthias Pinter; Kaan Boztug; Mattias Mandorfer; Michael Trauner; Thomas Reiberger
Journal:  J Gastroenterol       Date:  2021-12-11       Impact factor: 7.527

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.